Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,432 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Purified Human Dental Pulp Stem Cells Promote Osteogenic Regeneration.
Yasui T, Mabuchi Y, Toriumi H, Ebine T, Niibe K, Houlihan DD, Morikawa S, Onizawa K, Kawana H, Akazawa C, Suzuki N, Nakagawa T, Okano H, Matsuzaki Y. Yasui T, et al. J Dent Res. 2016 Feb;95(2):206-14. doi: 10.1177/0022034515610748. Epub 2015 Oct 22. J Dent Res. 2016. PMID: 26494655
Isolation of dental pulp stem cells with high osteogenic potential.
Yasui T, Mabuchi Y, Morikawa S, Onizawa K, Akazawa C, Nakagawa T, Okano H, Matsuzaki Y. Yasui T, et al. Inflamm Regen. 2017 Apr 10;37:8. doi: 10.1186/s41232-017-0039-4. eCollection 2017. Inflamm Regen. 2017. PMID: 29259707 Free PMC article. Review.
Prognostic outcomes in Japanese patients with metastatic castration-sensitive prostate cancer: Comparative assessments between conventional androgen deprivation therapy (ADT) and ADT with novel androgen receptor signal inhibitor.
Watanabe H, Nakane K, Takahara K, Naiki T, Yasui T, Shiroki R, Koie T, Miyake H. Watanabe H, et al. Among authors: yasui t. Int J Urol. 2024 May 19. doi: 10.1111/iju.15498. Online ahead of print. Int J Urol. 2024. PMID: 38764245
C-Reactive Protein Is a Potential Prognostic Marker in Patient with Advanced or Metastatic Urothelial Carcinoma Treated with Enfortumab Vedotin: A Multi-Center Retrospective Study.
Morikawa T, Naiki T, Sugiyama Y, Naiki-Ito A, Nagai T, Etani T, Iida K, Isobe T, Noda Y, Shimizu N, Aoki M, Gonda M, Banno R, Kubota H, Ando R, Umemoto Y, Kawai N, Yasui T. Morikawa T, et al. Among authors: yasui t. Cancers (Basel). 2024 Apr 28;16(9):1725. doi: 10.3390/cancers16091725. Cancers (Basel). 2024. PMID: 38730675 Free PMC article.
Effectiveness of switch therapy from tyrosine kinase inhibitors to immune checkpoint inhibitors: the need for biomarkers to establish treatment strategies in patients with metastatic renal cell carcinoma.
Tasaki Y, Hamamoto S, Furukawa-Hibi Y, Yasui T. Tasaki Y, et al. Among authors: yasui t. Transl Androl Urol. 2024 Apr 30;13(4):631-634. doi: 10.21037/tau-23-647. Epub 2024 Apr 12. Transl Androl Urol. 2024. PMID: 38721293 Free PMC article. No abstract available.
Renal Failure Without Hemodialysis Is a Risk Factor for Postoperative Complications in Colorectal Cancer Surgery.
Fujimoto T, Inoue S, Matsunaga T, Shimizu T, Mitsubuchi H, Matsuyoshi T, Matsuda K, Terasaka S, Yasui T, Kameda C, Ogura Y, Ueda J, Nakai K, Tokumoto M, Nishiyama K, Motoyama K, Nagai E, Nakafusa Y. Fujimoto T, et al. Among authors: yasui t. Cancer Diagn Progn. 2024 May 3;4(3):295-300. doi: 10.21873/cdp.10323. eCollection 2024 May-Jun. Cancer Diagn Progn. 2024. PMID: 38707737 Free PMC article.
1,432 results